Novartis Sues To Block Generic Reclast, Zometa Drugs
By Linda Chiem ( February 22, 2013, 1:58 PM EST) -- Novartis Pharmaceuticals Corp. filed a lawsuit Wednesday in New Jersey federal court seeking to bar more than a dozen drugmakers from making generic versions of its osteoporosis drug Reclast and oncology drug Zometa....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.